1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

NEWS

MesoTV: Chemotherapy + immunotherapy, another positive step in mesothelioma treatment

Drs. Anne Tsao of MD Anderson Cancer Center, Patrick Forde of Johns Hopkins, and James Stevenson of the Cleveland Clinic join Mary Hesdorffer to discuss a new clinical trial, Dream3r, a phase 3 study into the efficacy of combination chemotherapy with immunotherapy as first line treatment for mesothelioma.

Our sponsors

MesoTV is a program by the Mesothelioma Applied Research Foundation. This program is made possible by our generous sponsors: Maune Raichle Hartley French & Mudd, LLC (MRHFM)Belluck & FoxBristol Myers SquibbNovocureMerckThe Gori Law FirmEarly Lucarelli Sweeney & Meisenkothen.

Also...

In Other News

Survivorship Panel

Many mesothelioma patients beat their odds and go on to live rich, fulfilling lives. This panel has three long term patients who discuss the issues

Read More »

Share:

Facebook
Twitter
LinkedIn